Key facts
- This page summarizes Robert A. Anderson's Form 4 filing for bioAffinity Technologies, Inc. (BIAF).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 29 Mar 2024, 16:52.
Robert A. Anderson - 26 Feb 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)
- Reporting relationship
- Director
- Issuer ticker
- BIAF
- Reported as of
- 26 Feb 2024
- Net transaction value
- +$74,899
- SEC form
- 4
- Accepted by SEC
- 29 Mar 2024, 16:52:15 UTC
- Prior SEC filing
- 24 Jan 2024
- Next SEC filing
- 14 Jun 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Maria Zannes, as attorney-in-fact Robert Anderson
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert A. Anderson filed Form 4 for bioAffinity Technologies, Inc. (BIAF) on 29 Mar 2024.
Change
- Previous filing in this sequence was filed on 24 Jan 2024.
- Current net transaction value: +$74,899.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BIAF
transaction
Common Stock
Options Exercise
- Transaction value
- $74,899
- Shares
- +64,848
- Change %
- +114%
- Price
- $1.16
- Shares after
- 121,856
- Date
- 26 Feb 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
BIAF
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -64,848
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 26 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 64,848
- Exercise price
- $1.12
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This option vested in 7 equal monthly installments beginning on May 28, 2014 and the balance of such option vested on December 28, 2014.